Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA.
about
Structural determinants of host specificity of complement Factor H recruitment by Streptococcus pneumoniaeThe host immune dynamics of pneumococcal colonization: implications for novel vaccine developmentDifferential activation of inflammatory pathways in A549 type II pneumocytes by Streptococcus pneumoniae strains with different adherence properties.Both innate immunity and type 1 humoral immunity to Streptococcus pneumoniae are mediated by MyD88 but differ in their relative levels of dependence on toll-like receptor 2.Randomized controlled study of the safety and immunogenicity of pneumococcal vaccine formulations containing PhtD and detoxified pneumolysin with alum or adjuvant system AS02V in elderly adultsThe Pneumococcal Alpha-Glycerophosphate Oxidase Enhances Nasopharyngeal Colonization through Binding to Host Glycoconjugates.Differential PsaA-, PspA-, PspC-, and PdB-specific immune responses in a mouse model of pneumococcal carriage.Mapping of epitopes recognized by antibodies induced by immunization of mice with PspA and PspC.A novel ICOS-independent, but CD28- and SAP-dependent, pathway of T cell-dependent, polysaccharide-specific humoral immunity in response to intact Streptococcus pneumoniae versus pneumococcal conjugate vaccine.Antibodies to the iron uptake ABC transporter lipoproteins PiaA and PiuA promote opsonophagocytosis of Streptococcus pneumoniae.The human complement regulator factor H binds pneumococcal surface protein PspC via short consensus repeats 13 to 15.Identification of invasive serotype 1 pneumococcal isolates that express nonhemolytic pneumolysin.Development of Streptococcus pneumoniae Vaccines Using Live VectorsImpairment of pneumococcal antigen specific isotype-switched Igg memory B-cell immunity in HIV infected Malawian adults.The contribution of PspC to pneumococcal virulence varies between strains and is accomplished by both complement evasion and complement-independent mechanismsRelative roles of genetic background and variation in PspA in the ability of antibodies to PspA to protect against capsular type 3 and 4 strains of Streptococcus pneumoniaeTwo DHH subfamily 1 proteins contribute to pneumococcal virulence and confer protection against pneumococcal disease.The role of pneumolysin in mediating lung damage in a lethal pneumococcal pneumonia murine modelDelayed reconstitution of B cell immunity to pneumococcus in HIV-infected Malawian children on antiretroviral therapy.Genome sequence of Mycoplasma iowae strain 695, an unusual pathogen causing deaths in turkeysDevelopment of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae.Contributions of pneumolysin, pneumococcal surface protein A (PspA), and PspC to pathogenicity of Streptococcus pneumoniae D39 in a mouse model.Live attenuated Streptococcus pneumoniae strains induce serotype-independent mucosal and systemic protection in mice.Active Immunization with Pneumolysin versus 23-Valent Polysaccharide Vaccine for Streptococcus pneumoniae KeratitisRR06 activates transcription of spr1996 and cbpA in Streptococcus pneumoniae.Cross-reactivity of antipneumococcal surface protein C (PspC) antibodies with different strains and evaluation of inhibition of human complement factor H and secretory IgA binding via PspC.Pneumococcal vaccine development.Factor H binding to PspC of Streptococcus pneumoniae increases adherence to human cell lines in vitro and enhances invasion of mouse lungs in vivoNeutralizing antibodies elicited by a novel detoxified pneumolysin derivative, PlyD1, provide protection against both pneumococcal infection and lung injuryMultivalent Pneumococcal Protein Vaccines Comprising Pneumolysoid with Epitopes/Fragments of CbpA and/or PspA Elicit Strong and Broad Protection.Identification of genes that contribute to the pathogenesis of invasive pneumococcal disease by in vivo transcriptomic analysis.Streptococcus pneumoniae protein vaccine candidates: properties, activities and animal studies.Species-specific interaction of Streptococcus pneumoniae with human complement factor H.Characterization of protective mucosal and systemic immune responses elicited by pneumococcal surface protein PspA and PspC nasal vaccines against a respiratory pneumococcal challenge in mice.Antibodies to pneumococcal proteins PhtD, CbpA, and LytC in Filipino pregnant women and their infants in relation to pneumococcal carriageInvasive and noninvasive Streptococcus pneumoniae capsule and surface protein diversity following the use of a conjugate vaccineNatural Development of Antibodies against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Protein Antigens during the First 13 Years of Life.Safety, immunogenicity, and antibody persistence following an investigational Streptococcus pneumoniae and Haemophilus influenzae triple-protein vaccine in a phase 1 randomized controlled study in healthy adults.Broadly protective protein-based pneumococcal vaccine composed of pneumolysin toxoid-CbpA peptide recombinant fusion proteinOtitis-Prone Children Produce Functional Antibodies to Pneumolysin and Pneumococcal Polysaccharides.
P2860
Q27695722-4F69AEA0-EE44-4580-9342-379C0D326353Q28084920-F600F8DB-9EC6-42B5-A4C9-B2B4524472C9Q33239521-6B06D6EB-26CB-4A62-92C7-AB4FAEA00380Q33558186-88D57317-FAC0-449D-92A3-8911723BF756Q33601853-489E4307-ED22-4353-BFFD-6B26307DB66AQ33603644-26949BF2-FA28-4B59-BC67-13EB5FEA5F56Q33798317-1DDBBB11-37BE-4470-AA44-D252E30A1670Q33899358-50D505ED-461F-4D77-BA67-7D560D6C5056Q33944575-5744C873-A544-4645-BFE6-4BE212D99642Q34033151-70568AB2-8EE7-4318-A974-DA5F7F19DB73Q34132121-2A55086F-9B0B-4FBF-B2AE-C70F160DF41FQ34315525-5C044B39-F399-41DA-95B2-DD11B0B30ABAQ34316015-702577A7-393B-412F-A1F3-686A37D65431Q35040976-9E35A796-C572-46AC-A870-D4B244F99D8FQ35073802-F91A145B-3D68-4D23-8F78-85C756A4A859Q35165275-2396EEDA-1744-4E9E-A450-564C66B3A7BCQ35191928-F6D6D7A6-71EA-4A5A-BC4B-BAC7F08C5F0BQ35623322-C6A7B2AD-5A0E-472A-9548-369201B884EAQ35635685-34F5D050-25F8-451E-9181-721399FB3D82Q35668178-D82F9451-8903-4C9D-A5B3-FAAA05FDEE66Q35689099-49EB839C-190B-4522-B016-324EFB94A9A8Q35783885-EDB186A4-15E5-4349-8D2C-8EB38DB9F0E1Q35784046-52EA27EF-7346-4837-9095-5E2808B49B19Q35826641-A94B440F-4FC5-43AA-AD5B-D248B7C3DF65Q35855363-78C98861-F8DA-4BEC-8AC5-22D92BB0AA90Q35867202-BA1A7649-F55C-48F8-AD7C-A122D3240DFBQ35918513-2C511ED6-580A-4408-9F6C-947EAEA958B9Q35949810-1103E224-4277-4021-B333-7658D7C1240BQ36018158-3BB9120A-4BD8-4A38-9DCD-D86C32F428E1Q36087567-1322B295-5244-4E9E-B358-ED02FC43F5A7Q36163091-5CF02545-87D0-40C4-8968-CB58B9317886Q36558990-01834EA3-D3B2-4E70-8D97-3B35E5610A27Q36984721-56979ABA-768C-4136-AA7B-76E17186D1D0Q37190966-DCEC4930-2DC2-4208-8D42-B6355EB9CC0CQ37213916-6E5B9AB0-90C7-4755-9158-4965EF152506Q37335485-04B98E60-F1E3-4EBE-A11D-69242C5A8C43Q37396978-8C3C2CB5-B889-439B-894F-2E0D09F0FF2DQ37544974-57C75BEA-606A-48EA-ABF2-02779799CD67Q37635127-1B460FF5-A351-4298-9971-DCAA8BDDB76FQ37683735-27542F63-3FC7-4DE7-94AB-8BE37AC79D9F
P2860
Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Protection against Streptococc ...... ion with pneumolysin and CbpA.
@ast
Protection against Streptococc ...... ion with pneumolysin and CbpA.
@en
Protection against Streptococc ...... ion with pneumolysin and CbpA.
@nl
type
label
Protection against Streptococc ...... ion with pneumolysin and CbpA.
@ast
Protection against Streptococc ...... ion with pneumolysin and CbpA.
@en
Protection against Streptococc ...... ion with pneumolysin and CbpA.
@nl
prefLabel
Protection against Streptococc ...... ion with pneumolysin and CbpA.
@ast
Protection against Streptococc ...... ion with pneumolysin and CbpA.
@en
Protection against Streptococc ...... ion with pneumolysin and CbpA.
@nl
P2093
P2860
P1476
Protection against Streptococc ...... ion with pneumolysin and CbpA.
@en
P2093
A D Ogunniyi
J T Poolman
M C Woodrow
P2860
P304
P356
10.1128/IAI.69.10.5997-6003.2001
P407
P577
2001-10-01T00:00:00Z